Laplace Interventional Stock

Laplace is a medical device company that develops transcatheter tricuspid valve technology.

Sign up today and learn more about Laplace Interventional Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Laplace Interventional Stock

Laplace is a medical device company that develops transcatheter tricuspid valve technology. The company's transcatheter tricuspid valve technology offers an increase in life expectancy and an improvement to the quality of life to worldwide patients with tricuspid regurgitation.

Funding History

September 2021$7.9M
July 2023$12.9M

Management

Board Member

Todd Mortier

Board Member

Jenny Barba

Founder and CEO

Ramji Iyer

Board of Director

William Dai

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo